153 related articles for article (PubMed ID: 37204842)
1. TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients.
Alaraifi AK; Alessa M; Hijazi LO; Alayed AM; Alsalem AA
Acta Otorhinolaryngol Ital; 2023 Jun; 43(3):183-188. PubMed ID: 37204842
[TBL] [Abstract][Full Text] [Related]
2. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
[TBL] [Abstract][Full Text] [Related]
3. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
4. Risk of Thyroid Cancer in Euthyroid Asymptomatic Patients with Thyroid Nodules with an Emphasis on Family History of Thyroid Cancer.
Hwang SH; Kim EK; Moon HJ; Yoon JH; Kwak JY
Korean J Radiol; 2016; 17(2):255-63. PubMed ID: 26957911
[TBL] [Abstract][Full Text] [Related]
5. Serum TSH as a predictor of malignancy in indeterminate thyroid nodules.
Amado A; Castro B; Torre AP; Graça S; Tavares A; Póvoa A; Soares C; Gonçalves G
Ann R Coll Surg Engl; 2022 May; 104(5):380-384. PubMed ID: 34939834
[TBL] [Abstract][Full Text] [Related]
6. Serum TSH is not a risk factor for malignancy of pediatric thyroid nodules.
Wang G; Ren N; Wang S; Zhang X; Li Y; Sun N; Liu Q; Zhang J; Song W; Ni X
Endocr Relat Cancer; 2021 Apr; 28(4):247-255. PubMed ID: 33690161
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.
Al Dawish MA; Alwin Robert A; Thabet MA; Braham R
Cancer Inform; 2018; 17():1176935118765132. PubMed ID: 29581701
[TBL] [Abstract][Full Text] [Related]
8. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
[TBL] [Abstract][Full Text] [Related]
9. TSH Level and Risk of Malignancy in Patients with Bethesda Category IV Thyroid Nodules.
Fernández-Trujillo C; Pérez-Zaballos J; Rodríguez-Pérez CA; López-Plasencia Y; Marrero-Arencibia D; Cabrera-Galván JJ; Boronat M
Horm Cancer; 2020 Aug; 11(3-4):200-204. PubMed ID: 32266672
[TBL] [Abstract][Full Text] [Related]
10. Serum TSH Level as a Simple Efficient Tool to Assess the Risk of Thyroid Malignancy in Euthyroid Patients with Indeterminate Cytology - A Cohort Study.
Vinod A; Ramachandran R; Pillai AV; Padmanabhan DS; Ravindran GC; Babu MJC; Jacob P; Nair GC
Indian J Endocrinol Metab; 2022; 26(5):446-452. PubMed ID: 36618514
[TBL] [Abstract][Full Text] [Related]
11. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
Moon SS; Lee YS; Lee IK; Kim JG
Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
[TBL] [Abstract][Full Text] [Related]
12. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
13. Serum thyrotropin concentration in children with isolated thyroid nodules.
Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
15. Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.
Hulikal N; Re A; Banoth M; Chowhan AK; Yutla M; Sachan A
Acta Otorhinolaryngol Ital; 2020 Feb; 40(1):33-37. PubMed ID: 32275647
[TBL] [Abstract][Full Text] [Related]
16. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.
Polyzos SA; Kita M; Efstathiadou Z; Poulakos P; Slavakis A; Sofianou D; Flaris N; Leontsini M; Kourtis A; Avramidis A
J Cancer Res Clin Oncol; 2008 Sep; 134(9):953-60. PubMed ID: 18327610
[TBL] [Abstract][Full Text] [Related]
17. The McGill Thyroid Nodule Score's (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review.
Khalife S; Bouhabel S; Forest VI; Hier MP; Rochon L; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2016 May; 45(1):29. PubMed ID: 27142264
[TBL] [Abstract][Full Text] [Related]
18. Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
Golbert L; de Cristo AP; Faccin CS; Farenzena M; Folgierini H; Graudenz MS; Maia AL
PLoS One; 2017; 12(11):e0188123. PubMed ID: 29145466
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
[TBL] [Abstract][Full Text] [Related]
20. Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.
Boi F; Minerba L; Lai ML; Marziani B; Figus B; Spanu F; Borghero A; Mariotti S
J Endocrinol Invest; 2013 May; 36(5):313-20. PubMed ID: 22931861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
